Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-05 5:00 pm Purchase | 2021-11-05 | 13G | Sierra Oncology, Inc. SRRA | Vivo Capital IX, LLC | 1,935,853 14.800% | 480,277 (+33.00%) | Filing History |
| 2021-07-23 4:30 pm Purchase | 2021-07-19 | 13G | Sera Prognostics, Inc. SERA | Vivo Capital IX, LLC | 1,856,011 6.400% | 1,856,011 (New Position) | Filing History |
| 2021-04-01 4:33 pm Purchase | 2021-03-23 | 13G | Instil Bio, Inc. TIL | Vivo Capital IX, LLC | 624,339 9.700% | 624,339 (New Position) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX, LLC | 8,960,296 8.168% | -21,635,328 (-70.71%) | Filing History |
| 2021-02-12 4:30 pm Purchase | 2020-12-31 | 13G | Chinook Therapeutics, Inc. KDNY | Vivo Capital IX, LLC | 987,624 2.300% | 987,624 (New Position) | Filing History |
| 2021-02-12 4:30 pm Purchase | 2020-12-31 | 13G | Matinas BioPharma Holdings, Inc. MTNB | Vivo Capital IX, LLC | 105,493 2.600% | 105,493 (New Position) | Filing History |
| 2021-02-12 4:30 pm Purchase | 2020-12-31 | 13G | ESSA Pharma Inc. EPIX | Vivo Capital IX, LLC | 1,562,603 4.700% | 152,089 (+10.78%) | Filing History |
| 2021-02-12 4:30 pm Unchanged | 2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL | Vivo Capital IX, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2020-11-06 4:31 pm Purchase | 2020-10-29 | 13G | ESSA Pharma Inc. EPIX | Vivo Capital IX, LLC | 1,410,514 4.400% | 1,410,514 (New Position) | Filing History |
| 2020-10-28 4:31 pm Purchase | 2020-10-20 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Vivo Capital IX, LLC | 3,245,035 16.200% | 3,245,035 (New Position) | Filing History |
| 2020-07-29 4:35 pm Purchase | 2020-07-21 | 13G | ALX Oncology Holdings Inc. ALXO | Vivo Capital IX, LLC | 4,034,522 11.100% | 4,034,522 (New Position) | Filing History |